C Weiler

533 total citations
8 papers, 426 citations indexed

About

C Weiler is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, C Weiler has authored 8 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Hematology. Recurrent topics in C Weiler's work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Cancer Treatment and Pharmacology (2 papers). C Weiler is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Cancer Treatment and Pharmacology (2 papers). C Weiler collaborates with scholars based in United States and Germany. C Weiler's co-authors include John H. Glick, Donna Glover, Kevin R. Fox, DuPont Guerry, Morton M. Kligerman, PA Cassileth, C B Begg, J M Bennett, Marek J. Bozdech and Selwyn J. Hurwitz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

C Weiler

8 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Weiler United States	6	189	154	135	90	68	8	426
Barbara Rogers United States	10	133 0.7×	115 0.7×	100 0.7×	66 0.7×	28 0.4×	29	439
Marise Weil France	6	194 1.0×	234 1.5×	250 1.9×	56 0.6×	88 1.3×	10	591
Wasserman Th United States	9	102 0.5×	41 0.3×	73 0.5×	84 0.9×	15 0.2×	10	350
Frank Heinzelmann Germany	14	110 0.6×	79 0.5×	46 0.3×	111 1.2×	22 0.3×	37	443
Lagrange Jl France	10	128 0.7×	36 0.2×	93 0.7×	68 0.8×	25 0.4×	32	340
Jean‐Nicolas Munck France	12	214 1.1×	46 0.3×	71 0.5×	29 0.3×	19 0.3×	21	413
Larry L. Schenken United States	14	136 0.7×	17 0.1×	89 0.7×	133 1.5×	21 0.3×	34	411
Ö. Ataman United Kingdom	14	313 1.7×	78 0.5×	169 1.3×	48 0.5×	16 0.2×	23	539
Phillips Tl United States	12	96 0.5×	25 0.2×	68 0.5×	136 1.5×	15 0.2×	22	466
Ettinger Ds United States	12	170 0.9×	17 0.1×	116 0.9×	61 0.7×	18 0.3×	21	429

Countries citing papers authored by C Weiler

Since Specialization

Citations

This map shows the geographic impact of C Weiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Weiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Weiler more than expected).

Fields of papers citing papers by C Weiler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Weiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Weiler. The network helps show where C Weiler may publish in the future.

Co-authorship network of co-authors of C Weiler

This figure shows the co-authorship network connecting the top 25 collaborators of C Weiler. A scholar is included among the top collaborators of C Weiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Weiler. C Weiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Wolf, Bernhard, et al.. (1996). Drug Targeting and Metabolic Investigations of Cryoprepared Tumor Cells with Analytical Electron Energy Loss Spectroscopy. Tumor Biology. 17(4). 234–250. 7 indexed citations

2.

Weiler, C, et al.. (1988). Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year update.. PubMed. 297–301. 8 indexed citations

3.

Glover, Donna, John H. Glick, C Weiler, Kevin R. Fox, & DuPont Guerry. (1987). WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.. Journal of Clinical Oncology. 5(4). 574–578. 151 indexed citations

4.

Hurwitz, Selwyn J., et al.. (1986). Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid].. PubMed. 70(12). 1389–93. 37 indexed citations

5.

Glover, Donna, et al.. (1986). WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial.. Journal of Clinical Oncology. 4(4). 584–588. 100 indexed citations

6.

Cassileth, PA, et al.. (1984). A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia. Blood. 63(4). 843–847. 118 indexed citations

7.

Cassileth, Peter A., et al.. (1981). Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.. PubMed. 4(2). 125–8. 4 indexed citations

8.

Carabell, Steven C., et al.. (1979). Misonidazole and radiotherapy (RT) in the treatment of malignant glioma: A phase II trial. International Journal of Radiation Oncology*Biology*Physics. 5. 194–194. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact